These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24535638)

  • 1. Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease.
    Maresca F; Di Palma V; Bevilacqua M; Uccello G; Taglialatela V; Giaquinto A; Esposito G; Trimarco B; Cirillo P
    Angiology; 2015 Jan; 66(1):8-24. PubMed ID: 24535638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines at the crossroad between obesity and cardiovascular disease.
    Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
    Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions.
    Ruscica M; Baragetti A; Catapano AL; Norata GD
    Nutr Metab Cardiovasc Dis; 2017 May; 27(5):379-395. PubMed ID: 28237179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipokines and the cardiovascular system: mechanisms mediating health and disease.
    Northcott JM; Yeganeh A; Taylor CG; Zahradka P; Wigle JT
    Can J Physiol Pharmacol; 2012 Aug; 90(8):1029-59. PubMed ID: 22646022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Roles for Adipose Tissue in Cardiovascular Disease.
    Ha EE; Bauer RC
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):e137-e144. PubMed ID: 30354196
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.
    Jia G; Aroor AR; Sowers JR
    Cardiovasc Res; 2017 Jul; 113(9):1055-1063. PubMed ID: 28838041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis and obesity: cellular bases.
    Lorenzet R; Napoleone E; Cutrone A; Donati MB
    Thromb Res; 2012 Mar; 129(3):285-9. PubMed ID: 22078462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: A pilot study.
    Wen MJ; Hsieh CH; Wu CZ; Hsiao FC; Hsia TL; Hung YJ; Pei D
    Obes Res Clin Pract; 2013; 7(3):e206-10. PubMed ID: 23697589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Adipokines in Predicting Cardiovascular Outcome: Explaining the Obesity Paradox.
    Wolk R; Bertolet M; Singh P; Brooks MM; Pratley RE; Frye RL; Mooradian AD; Rutter MK; Calvin AD; Chaitman BR; Somers VK;
    Mayo Clin Proc; 2016 Jul; 91(7):858-66. PubMed ID: 27289411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers in the field of obesity and its related comorbidities.
    Katsareli EA; Dedoussis GV
    Expert Opin Ther Targets; 2014 Apr; 18(4):385-401. PubMed ID: 24479492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction.
    Lynch M; Ahern T; Sweeney CM; Malara A; Tobin AM; O'Shea D; Kirby B
    Int J Dermatol; 2017 Nov; 56(11):1103-1118. PubMed ID: 28762474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fat mass expansion, fatty acids and adipokines: metabolic markers and risk factors for cardiovascular pathologies].
    Lafontan M
    Ann Pharm Fr; 2013 Jan; 71(1):13-26. PubMed ID: 23348852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocytokines in relation to cardiovascular disease.
    Van de Voorde J; Pauwels B; Boydens C; Decaluwé K
    Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Obesity paradox].
    Aursulesei V; Cozma A; Datcu MD
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1006-15. PubMed ID: 20191867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.
    Panera N; Della Corte C; Crudele A; Stronati L; Nobili V; Alisi A
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):393-403. PubMed ID: 26654761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint.
    Achike FI; To NH; Wang H; Kwan CY
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):1-10. PubMed ID: 21083697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of adiposity as a determinant of an inflammatory milieu.
    Calabrò P; Limongelli G; Pacileo G; Di Salvo G; Golino P; Calabrò R
    J Cardiovasc Med (Hagerstown); 2008 May; 9(5):450-60. PubMed ID: 18403996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of C-reactive protein to obesity, adipose tissue hormones and cardiovascular risk factors in men treated with early percutaneous intervention in course of acute myocardial infarction.
    Piestrzeniewicz K; Łuczak K; Komorowski J; Jankiewicz-Wika J; Goch JH
    Neuro Endocrinol Lett; 2007 Aug; 28(4):427-32. PubMed ID: 17693973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of chemokines to BMI and insulin resistance at ages 18-21.
    Ognjanovic S; Jacobs DR; Steinberger J; Moran A; Sinaiko AR
    Int J Obes (Lond); 2013 Mar; 37(3):420-3. PubMed ID: 22508338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.